Litt’s Drug profile for Heparin


Geriatric
  • Trade Names: Calcilean; Calciparin; Caprin; Hep-Flush (Wyeth); Hep-Lock; Hepalean; Heparin-Leo; Heparine; Liquemin; Uniparin; Viaflex (Baxter)
  • Indications: Venous thrombosis, pulmonary embolism, intravascular coagulation, peripheral arterial embolism
  • Class: Anticoagulant (antithrombotic), Heparinoid
  • Half-life: 2 hours

Investigated for treating COVID-19.

A higher incidence of bleeding has been reported in patients over 60 years of age, especially women.

Contra-indicated in patients with severe thrombocyopenia.

Please login to view the rest of this drug profile.

Page last updated 02/13/2026

Symbol key

Incidence - Help

<1% 1‑5% 5‑10% 10‑15% 15‑20% 20‑30% >30%

Seriousness - Help

Hospitalization possible
Life threatening
Fatal

Warnings in other populations - Help

BreastfeedingBreast feeding

GeriatricGeriatric

PediatricPediatric